235 related articles for article (PubMed ID: 18606985)
1. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.
Hartmann E; Fernàndez V; Moreno V; Valls J; Hernández L; Bosch F; Abrisqueta P; Klapper W; Dreyling M; Hoster E; Müller-Hermelink HK; Ott G; Rosenwald A; Campo E
J Clin Oncol; 2008 Oct; 26(30):4966-72. PubMed ID: 18606985
[TBL] [Abstract][Full Text] [Related]
2. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
[TBL] [Abstract][Full Text] [Related]
4. Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.
Kienle D; Katzenberger T; Ott G; Saupe D; Benner A; Kohlhammer H; Barth TF; Höller S; Kalla J; Rosenwald A; Müller-Hermelink HK; Möller P; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2007 Jul; 25(19):2770-7. PubMed ID: 17563396
[TBL] [Abstract][Full Text] [Related]
5. Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders.
Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R
Diagn Mol Pathol; 2008 Mar; 17(1):39-50. PubMed ID: 18303407
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
[TBL] [Abstract][Full Text] [Related]
7. Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.
Jardin F; Picquenot JM; Parmentier F; Ruminy P; Cornic M; Penther D; Bertrand P; Lanic H; Cassuto O; Humbrecht C; Lemasle E; Wautier A; Bastard C; Tilly H
Br J Haematol; 2009 Sep; 146(6):607-18. PubMed ID: 19594747
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia.
Miranda RN; Briggs RC; Kinney MC; Veno PA; Hammer RD; Cousar JB
Mod Pathol; 2000 Dec; 13(12):1308-14. PubMed ID: 11144927
[TBL] [Abstract][Full Text] [Related]
9. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA
Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536
[TBL] [Abstract][Full Text] [Related]
11. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
Tiemann M; Schrader C; Klapper W; Dreyling MH; Campo E; Norton A; Berger F; Kluin P; Ott G; Pileri S; Pedrinis E; Feller AC; Merz H; Janssen D; Hansmann ML; Krieken H; Möller P; Stein H; Unterhalt M; Hiddemann W; Parwaresch R;
Br J Haematol; 2005 Oct; 131(1):29-38. PubMed ID: 16173960
[TBL] [Abstract][Full Text] [Related]
12. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival.
Wang X; Asplund AC; Porwit A; Flygare J; Smith CI; Christensson B; Sander B
Br J Haematol; 2008 Oct; 143(2):248-52. PubMed ID: 18729857
[TBL] [Abstract][Full Text] [Related]
13. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.
Medeiros LJ; Hai S; Thomazy VA; Estalilla OC; Romaguera J; Luthra R
Mod Pathol; 2002 May; 15(5):556-64. PubMed ID: 12011261
[TBL] [Abstract][Full Text] [Related]
14. Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples.
Scicchitano MS; Dalmas DA; Bertiaux MA; Anderson SM; Turner LR; Thomas RA; Mirable R; Boyce RW
J Histochem Cytochem; 2006 Nov; 54(11):1229-37. PubMed ID: 16864893
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues.
Koch I; Slotta-Huspenina J; Hollweck R; Anastasov N; Hofler H; Quintanilla-Martinez L; Fend F
Diagn Mol Pathol; 2006 Sep; 15(3):149-56. PubMed ID: 16932070
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.
Sánchez-Navarro I; Gámez-Pozo A; González-Barón M; Pinto-Marín A; Hardisson D; López R; Madero R; Cejas P; Mendiola M; Espinosa E; Vara JA
Biotechniques; 2010 May; 48(5):389-97. PubMed ID: 20569212
[TBL] [Abstract][Full Text] [Related]
17. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
Martínez N; Camacho FI; Algara P; Rodríguez A; Dopazo A; Ruíz-Ballesteros E; Martín P; Martínez-Climent JA; García-Conde J; Menárguez J; Solano F; Mollejo M; Piris MA
Cancer Res; 2003 Dec; 63(23):8226-32. PubMed ID: 14678979
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
[TBL] [Abstract][Full Text] [Related]
19. Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67.
Kimura Y; Sato K; Arakawa F; Karube K; Nomura Y; Shimizu K; Aoki R; Hashikawa K; Yoshida S; Kiyasu J; Takeuchi M; Nino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Kikuchi M; Ohshima K
Cancer Sci; 2010 Mar; 101(3):806-14. PubMed ID: 20002441
[TBL] [Abstract][Full Text] [Related]
20. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
